Recently, there has been a renewed interest in calreticulin due to a discovery of calreticulin gene variants associated with chronic blood tumours known as myeloproliferative neoplasm (MPN).94, 95, 96. The gene discussed is CALR; the disease is myeloproliferative disorder.